Literature DB >> 499073

Impact of continuously administered catechol estrogens on uterine growth and luteinizing hormone secretion.

C P Martucci, J Fishman.   

Abstract

The biological activity of a series of natural catechol estrogens was examined under conditions of continuous administration. 2-Hydroxyestradiol (2OH-E2), 2-methoxyestradiol (2MeOE2), 4-hydroxyestrone (4OH-E1), 4-methoxyestradiol (4MeOE2), 2-hydroxyestrone (2OH-E1), and 4-methoxyestrone (4MeOE1) were delivered at the rate of 1 microgram/h from osmotic pumps implanted in ovariectomized rats. Uterine growth and plasma LH concentrations were measured 24, 48, and 72 h after implantation. Little or no uterotropic activity was exhibited by the 2-hydroxylated metabolites 2OH-E1 and 2MeOE2 at any interval, while 2OH-E2 exhibited anomalous uterotropic activity, which terminated at 48 h. The 4-hydroxylated compounds 4MeOE2, 4OH-E1, and 4MeOE1 all produced substantial and progressive uterine growth. Tonic LH secretion was suppressed by 2OH-E2, 4OH-E1, and 4MeOE1 in proportion to their uterotropic activity. 2OH-E1 was the only substance which increased plasma LH concentrations. The nuclear receptor occupancy by 2OH-E2 was substantially shorter than that of E2. Binding studies of the test and other related estrogens to the uterine cytosol estradiol receptor showed that their relative binding affinities in many instances did not correlate with their biological activities.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 499073     DOI: 10.1210/endo-105-6-1288

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Estrogen and catechol amine metabolism: possible interaction during pregnancy.

Authors:  E R Barnea; F Naftolin
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

2.  2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells.

Authors:  D C Spink; D W Lincoln; H W Dickerman; J F Gierthy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 3.  Importance of catecholestrogens in the regulation of the ovarian cycle.

Authors:  P Ball; G Emons; R Knuppen
Journal:  Arch Gynecol       Date:  1982

4.  3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound.

Authors:  G Kranzfelder; R W Hartmann; E von Angerer; H Schönenberger; A E Bogden
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

5.  On the mechanism of estrogen receptor replenishment: recycling, resynthesis and/or processing.

Authors:  J A Kassis; J Gorski
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

Review 6.  Rate-controlled drug dosage.

Authors:  J Urquhart
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

7.  Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.

Authors:  Jehana James; Daryl J Murry; Anthony M Treston; Anna Maria Storniolo; George W Sledge; Carolyn Sidor; Kathy D Miller
Journal:  Invest New Drugs       Date:  2006-09-13       Impact factor: 3.850

8.  Synthesis and evaluation of catechol analogs of diethylstilbestrol on a hormone-dependent human mammary carcinoma implanted in nude mice.

Authors:  M R Schneider; H Schönenberger; R T Michel; H P Fortmeyer
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

Review 9.  Aromatase inhibitors in malignant diseases of aging.

Authors:  D C Johannessen; P E Lønning
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

10.  Radiometric analysis of biological oxidations in man: sex differences in estradiol metabolism.

Authors:  J Fishman; H L Bradlow; J Schneider; K E Anderson; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.